help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reisman, D.
Right arrow Articles by Thompson, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reisman, D.
Right arrow Articles by Thompson, E. A.

Molecular Endocrinology, Vol 9, 1500-1509, Copyright © 1995 by Endocrine Society


ARTICLES

Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells

D Reisman and EA Thompson
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston 77550-0645, USA.

Glucocorticoids cause G0/G1 arrest of lymphoid cells. This is due, at least in part, to a decrease in the abundance of the G1 progression factor, cyclin D3. The mRNA encoding cyclin D3 (CcnD3 mRNA) is rapidly down-regulated when dexamethasone is added to P1798 murine T lymphoma cells. Fifty percent maximum inhibition is observed within about 2 h. Maximum inhibition of 75-85% obtains within 4-5 h. Cyclin D3 protein has a half-life of about 0.5 h in P1798 cells. Consequently, the abundance of cyclin D3 protein decreases in parallel with the abundance of CcnD3 mRNA. The effects of glucocorticoids are reversible. CcnD3 mRNA returns to near control levels within 2-3 h after removal of dexamethasone. Cyclin D3 protein recovers somewhat more slowly. The data indicate that glucocorticoids regulate the abundance of cyclin D3 mRNA. There is no significant decrease in nuclear run-on transcription of CcnD3 within 6 h after addition of glucocorticoids, although transcription is inhibited more than 80% after 24 h in the presence of dexamethasone. CcnD3 mRNA is very stable in mid-log phase P1798 cells, with a half-life of more than 8 h. The half-life of CcnD3 mRNA in glucocorticoid-treated cells is less than 1 h. Actinomycin D blocks the effects of glucocorticoids, suggesting that dexamethasone induces a substance that increases the turnover rate of CcnD3 mRNA. Regulation of CcnD3 mRNA abundance and of CcnD3 transcription has been studied in cells arrested at the G1/S interface by thymidine blockade. Glucocorticoids down-regulate CcnD3 mRNA in the absence of cell cycle progression. This observation indicates that glucocorticoid inhibition of cyclin D3 expression is not a secondary consequence of cell cycle arrest. However, glucocorticoids have no significant effect on transcription of CcnD3 in G1/S phase-arrested cells. Inhibition of transcription of CcnD3 is a delayed response and probably reflects withdrawal into a G0 state, rather than any proximal consequence of glucocorticoid action. Destabilization of CcnD3 mRNA appears to be a direct effect of glucocorticoids, independent of cell cycle progression, and mediated by a glucocorticoid-induced protein(s) that accelerates the degradation of CcnD3 mRNA.


This article has been cited by other articles:


Home page
Toxicol SciHome page
X. Fang, L. Zhang, Y. Feng, Y. Zhao, and J. Dai
Immunotoxic Effects of Perfluorononanoic Acid on BALB/c Mice
Toxicol. Sci., October 1, 2008; 105(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Fingerle-Rowson, P. Koch, R. Bikoff, X. Lin, C. N. Metz, F. S. Dhabhar, A. Meinhardt, and R. Bucala
Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo
Am. J. Pathol., January 1, 2003; 162(1): 47 - 56.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee
Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Rose, B. E. Smith, and D. G. Maloney
Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects
Blood, August 13, 2002; 100(5): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Grundschober, F. Delaunay, A. Puhlhofer, G. Triqueneaux, V. Laudet, T. Bartfai, and P. Nef
Circadian Regulation of Diverse Gene Products Revealed by mRNA Expression Profiling of Synchronized Fibroblasts
J. Biol. Chem., December 7, 2001; 276(50): 46751 - 46758.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R. Newton
Molecular mechanisms of glucocorticoid action: what is important?
Thorax, July 1, 2000; 55(7): 603 - 613.
[Full Text]


Home page
Mol. Endocrinol.Home page
M. K. R. Samuelsson, A. Pazirandeh, B. Davani, and S. Okret
p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells
Mol. Endocrinol., November 1, 1999; 13(11): 1811 - 1822.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. Fernandes, E. Guida, V. Koutsoubos, T. Harris, P. Vadiveloo, J. W. Wilson, and A. G. Stewart
Glucocorticoids Inhibit Proliferation, Cyclin D1 Expression, and Retinoblastoma Protein Phosphorylation, but Not Activity of the Extracellular-Regulated Kinases in Human Cultured Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 77 - 88.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
N. Baghdassarian, A. Peiretti, E. Devaux, P. André Bryon, and M. Ffrench
Involvement of p27Kip1 in the G1- and S/G2-phase Lengthening Mediated by Glucocorticoids in Normal Human Lymphocytes
Cell Growth Differ., June 1, 1999; 10(6): 405 - 412.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
Q. Zhang, X. Wang, and D. J. Wolgemuth
Developmentally Regulated Expression of Cyclin D3 and Its Potential in Vivo Interacting Proteins during Murine Gametogenesis
Endocrinology, June 1, 1999; 140(6): 2790 - 2800.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Corroyer, E. Nabeyrat, and A. Clement
Involvement of the Cell Cycle Inhibitor CIP1/WAF1 in Lung Alveolar Epithelial Cell Growth Arrest Induced by Glucocorticoids
Endocrinology, September 1, 1997; 138(9): 3677 - 3685.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Ramalingam, A. Hirai, and E. A. Thompson
Glucocorticoid Inhibition of Fibroblast Proliferation and Regulation of the Cyclin Kinase Inhibitor p21Cip1
Mol. Endocrinol., May 1, 1997; 11(5): 577 - 586.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. A. Garcia-Gras, P. Chi, and E. A. Thompson
Glucocorticoid-mediated Destabilization of Cyclin D3 mRNA Involves RNA-Protein Interactions in the 3'-Untranslated Region of the mRNA
J. Biol. Chem., July 14, 2000; 275(29): 22001 - 22008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel
Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES
J. Biol. Chem., June 23, 2000; 275(26): 19992 - 20001.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society